We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen to Gain Eye Disease Blockbuster Drug in $28B Horizon Therapeutics Buyout
Amgen to Gain Eye Disease Blockbuster Drug in $28B Horizon Therapeutics Buyout
In the biggest pharmaceutical purchase announced this year, Amgen has inked a $28 billion deal with Horizon Therapeutics, gaining access to one blockbuster eye drug and two others that are future revenue-drivers.